To evaluate muscle injury using magnetic resonance imaging after an intragluteal injection of Diclofenac sodium 75mg/ 3ml

A prospective open label single arm single centre exploratory evaluation of muscle injury using magnetic resonance imaging after an intragluteal injection of Diclofenac sodium (Generic) - 75 mg/3mL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/024099

Enrollment

Registered

2020-03-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Diclofenac Sodium 75 mg per 3 ml: Diclofenac Sodium 75 mg per 3 ml will be injected for one time only by intragluteal route Control Intervention1: NIl: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Male above 18 years

Exclusion criteria

Exclusion criteria: contraindications of Diclofenac sodium

Design outcomes

Primary

Measure	Time frame
to evaluate muscle injury using MRI following a diclofenac 75mg/3ml intragluteal injectionTimepoint: magnetic resonance imaging will be done at 2,12,22,32,47,62,92,122,182,242 min as well 7.5 hr after administration	—

Secondary

Measure	Time frame
to observe any change in the inflammatory biomarkers following a diclofenac 75 mg/ 3ml intragluteal injectionTimepoint: magnetic resonance imaging will be done at 2,12,22,32,47,62,92,122,182,242 min as well 7.5 hr after administration	—

Countries

India

Contacts

Public ContactDr Dushyant Balat

Apollo Hospitals International Ltd

drdushyant.balat@gmail.com9825015055

Outcome results